OCT 16, 2018 7:00 AM PDT

Empower your Laboratory with Total Value of Ownership: Do you know the total value that lies within and beyond your laboratory walls?

Sponsored by: Abbott
Speakers
  • Group CEO, Labexa Group, France; CEO & Founder, Gontard & Cie, Switzerland
    Biography
      Patrick Gontard possesses more than 25 years of medical industry experience, in a variety of senior leadership roles across laboratories, hospitals, and professional medical associations.
      Known as a subject matter expert on the topic of Total Cost of Ownership (TCO), Mr. Gontard has developed and implemented a TCO model, which has been applied in laboratory settings to become an evidence based, real life management tool for calculating and controlling costs related to laboratory and hospital operational efficiency.
      Responsible for restructuring and management, including commercial and scientific leadership in various laboratories throughout Europe and the Middle East, Mr. Gontard's TCO methodology has helped to uncover and quantify hidden or indirect costs and deliver operational efficiencies and improvements in profitability.
      Patrick has perfected his Total Cost of Ownership model over the years, working for organizations such as Viollier the second largest Swiss lab group, Integrated Diagnostics in Egypt, Citilab the second largest lab group in Russia, and currently is the lab CEO at Exalab in France.
    • Director of Strategy, Abbott Diagnostics
      Biography
        Paul Clarke is the Strategy Director for Abbott Diagnostics, Asia Pacific.

        Paul has more than 20 years of experience in Asia Pacific, 14 of which have been in the Medical Industry. He has specialized in the area of Value Based Healthcare, helping hospitals and laboratories quantify the financial and operational benefits of purchasing based on Total Value of Ownership (TVO)

        In his role at Abbott Diagnostics, he has implemented and delivered TVO models, which have been applied in both public and private laboratory settings to become evidence based, healthcare management tools for calculating and controlling costs and delivering and quantifying value both inside the laboratory and beyond.

        This TVO philosophy has helped healthcare institutions develop procurement models which facilitate better purchasing decisions by reducing risk, unlocking value, resulting in an overall reduction in the cost of healthcare.
      • Global Marketing Manager for Alinity ci-series Immunoassay and Clinical Chemistry Reagents, Abbott Diagnostics
        Biography
          Jose joined Abbott in 2003 as a Technical Support scientist for Immunoassays on Abbott's legacy platforms, TDx and AxSYM. Since then, he has held several roles throughout the organization, including Operations, R&D, Scientific Affairs in Latin America and Canada, and most recently, Global Marketing. Currently, Jose leads the marketing team responsible for bringing to market assays for the Alinity ci-series.

          Jose received his Bachelor of Science degree in Molecular Biology & Microbiology from the University of Central Florida and a Doctorate degree in Biological Sciences from Northwestern University.

        Abstract
        DATE:  October 16, 2018
        TIME:   7:00am PDT, 10:00am EDT, 4:00pm CEST
         
        In today’s healthcare environment, leaders are increasingly asked to demonstrate value in terms of operational and clinical care excellence across their healthcare system. The clinical laboratory is viewed as an important contributor to key performance indicators, and as a result, laboratory managers want to maximize the value that the lab brings to their institutions.
         
        The concept of total value of ownership considers all aspects of a lab’s processes and equipment and identifies areas where improvements can be made to maximize value. When the lab delivers services to its full potential, it can help improve outcomes system-wide, enabling the institution to make a positive impact on patient outcomes.
         
        In this webinar, you will:
        • learn about the Total Value of Ownership (TVO) and Total Cost of Ownership (TCO) methodologies,
        • understand how you can apply these methodologies to improve your laboratory’s operational performance and maximize its value to the organization, and
        • hear first-hand experiences, like:
          • a TVO-based analysis conducted by Abbott for the Korea Clinical Laboratory, and
          • a comparative TCO analysis of 5 leading analytical platforms, including the new Alinity ci-series, performed by an independent laboratory
         
        Join the discussion on October 16th and discover more from our experts about how the TVO and TCO methodologies can impact your laboratory today.

        Show Resources
        You May Also Like
        SEP 10, 2020 9:00 AM PDT
        C.E. CREDITS
        SEP 10, 2020 9:00 AM PDT
        Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
        NOV 18, 2020 8:00 AM PST
        C.E. CREDITS
        NOV 18, 2020 8:00 AM PST
        DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
        JUN 09, 2020 10:00 AM PDT
        C.E. CREDITS
        JUN 09, 2020 10:00 AM PDT
        DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
        NOV 16, 2020 8:00 AM PST
        C.E. CREDITS
        NOV 16, 2020 8:00 AM PST
        Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
        JUL 22, 2020 10:00 AM PDT
        C.E. CREDITS
        JUL 22, 2020 10:00 AM PDT
        DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
        OCT 29, 2020 6:00 AM PDT
        C.E. CREDITS
        OCT 29, 2020 6:00 AM PDT
        Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
        Loading Comments...
        Show Resources